Home

Concord Biotech Ltd PE Ratio

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PE

72.2

Last updated on: Jan 13, 2025

Key Highlights

  • The P/E Ratio of Concord Biotech Ltd is 72.2 as of 13 Jan 9.00 AM .
  • The P/E Ratio of Concord Biotech Ltd changed from 51.7 on March 2024 to 51.7 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Latest Trading Price of Concord Biotech Ltd is ₹ 2263 as of 13 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Concord Biotech Ltd

No data available

Company Fundamentals for Concord Biotech Ltd

Image

Concord Biotech Ltd

NSE: CONCORDBIO

Share Price

₹ 2263.8

8.45 (0.37%)

stock direction

Last updated on: Jan 13, 2025

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Jan 20252263.8
10 Jan 20252255.35
09 Jan 20252320.25
08 Jan 20252262.6
07 Jan 20252174.4
06 Jan 20252158.6
03 Jan 20252088
02 Jan 20252121.15
01 Jan 20252149.1
31 Dec 20242210.7

SWOT Analysis Of Concord Biotech Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Concord Biotech Ltd

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Concord Biotech Ltd23683
Sun Pharmaceuticals Industries Ltd418936
Divis Laboratories Ltd152157
Cipla Ltd116200
Dr Reddys Laboratories Ltd111325

PE Ratio of Concord Biotech Ltd Explained

``

23683

Market cap

327

Earnings

72.2X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Concord Biotech Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Concord Biotech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Concord Biotech Ltd

No data available

* All values are in %

About Concord Biotech Ltd

  • Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
  • Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
  • Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

Concord Biotech Ltd News Hub

Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter

Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 as against

Read more

2024-08-09 00:00:00

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Control Syst

Read more

2024-08-29 00:00:00

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024 Pow

Read more

2024-11-06 00:00:00

Concord Biotech consolidated net profit rises 18.17% in the September 2024 quarter

Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September 2024 as a

Read more

2024-11-11 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Concord Biotech Ltd

What is the current PE Ratio of Concord Biotech Ltd?

The Current PE Ratio of Concord Biotech Ltd is 72.21 as on 13 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 13 Jan 2025.

What was the PE Ratio of Concord Biotech Ltd last year?

The PE Ratio of Concord Biotech Ltd was 0.0 last year, now the PE ratio is 72.21, showing a year-on-year growth of -%.

What does the PE Ratio of Concord Biotech Ltd indicate about its stock?

The PE Ratio of Concord Biotech Ltd is 72.21. This ratio indicates that investors are willing to pay 72.21 times the earnings per share for each share of Concord Biotech Ltd.

What is the PE Ratio Growth of Concord Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Concord Biotech Ltd grew by -% whereas, the EPS ratio grew by 60.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions